2 results
Approved WMOCompleted
Primary:* To determine if alisertib improves overall response rate (ORR; complete response [CR] plus partial response [PR]) versus a selection of single agents in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)* To determine…
Approved WMORecruiting
We started to evaluated the feasibility of subcutaneous EEG electrodes in epilepsy patients undergoing VNS therapy in a pilot study. This part is currently finished.Currenrly, we are extending the cohort and aim to identify biomarkers to predict…